Artal Group as of June 30, 2021
Portfolio Holdings for Artal Group
Artal Group holds 144 positions in its portfolio as reported in the June 2021 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Ww Intl (WW) | 10.9 | $536M | 15M | 36.14 | |
Lexicon Pharmaceuticals Com New (LXRX) | 6.6 | $327M | 71M | 4.59 | |
Beigene Sponsored Adr (BGNE) | 5.9 | $292M | 850k | 343.19 | |
Citigroup Com New Call Option (C) | 3.9 | $195M | 2.8M | 70.75 | |
Seer Com Cl A (SEER) | 3.7 | $183M | 5.6M | 32.78 | |
Acceleron Pharma | 3.6 | $176M | 1.4M | 125.49 | |
Argenx Se Sponsored Adr (ARGX) | 3.1 | $151M | 500k | 301.07 | |
Mirati Therapeutics | 2.8 | $137M | 850k | 161.53 | |
Alnylam Pharmaceuticals (ALNY) | 2.6 | $127M | 750k | 169.52 | |
General Motors Company Call Option (GM) | 2.4 | $118M | 2.0M | 59.17 | |
Fate Therapeutics (FATE) | 2.4 | $117M | 1.4M | 86.79 | |
Rubius Therapeutics | 2.3 | $113M | 4.6M | 24.41 | |
Morphic Hldg (MORF) | 2.1 | $104M | 1.8M | 57.39 | |
Igm Biosciences (IGMS) | 1.9 | $92M | 1.1M | 83.20 | |
Generation Bio (GBIO) | 1.5 | $76M | 2.8M | 26.90 | |
Intel Corporation Call Option (INTC) | 1.5 | $73M | 1.3M | 56.14 | |
Bristol Myers Squibb Call Option (BMY) | 1.4 | $67M | 1.0M | 66.82 | |
I Mab Sponsored Ads (IMAB) | 1.3 | $63M | 750k | 83.95 | |
Schrodinger (SDGR) | 1.2 | $60M | 797k | 75.61 | |
Scholar Rock Hldg Corp (SRRK) | 1.2 | $58M | 2.0M | 28.90 | |
Sage Therapeutics (SAGE) | 1.2 | $57M | 1.0M | 56.81 | |
Ford Motor Company Call Option (F) | 1.1 | $52M | 3.5M | 14.86 | |
Cerevel Therapeutics Hldng I (CERE) | 1.0 | $51M | 2.0M | 25.62 | |
Allovir (ALVR) | 0.9 | $46M | 2.3M | 19.74 | |
Springworks Therapeutics (SWTX) | 0.8 | $41M | 500k | 82.41 | |
Intellia Therapeutics (NTLA) | 0.8 | $41M | 250k | 161.91 | |
Denali Therapeutics (DNLI) | 0.8 | $39M | 500k | 78.44 | |
Biohaven Pharmaceutical Holding | 0.8 | $39M | 400k | 97.08 | |
Oatly Group Ab Sponsored Ads (OTLY) | 0.7 | $37M | 1.5M | 24.46 | |
Amicus Therapeutics (FOLD) | 0.7 | $36M | 3.8M | 9.64 | |
Replimune Group (REPL) | 0.7 | $35M | 900k | 38.42 | |
Krystal Biotech (KRYS) | 0.7 | $34M | 500k | 68.00 | |
Agenus Com New (AGEN) | 0.7 | $33M | 6.0M | 5.49 | |
Kronos Bio (KRON) | 0.6 | $32M | 1.3M | 23.95 | |
Tg Therapeutics (TGTX) | 0.6 | $31M | 800k | 38.79 | |
Talaris Therapeutics | 0.6 | $30M | 2.1M | 14.69 | |
Verve Therapeutics (VERV) | 0.6 | $30M | 500k | 60.25 | |
Dicerna Pharmaceuticals | 0.6 | $30M | 800k | 37.32 | |
Freeport-mcmoran CL B Call Option (FCX) | 0.6 | $28M | 750k | 37.11 | |
Alx Oncology Hldgs (ALXO) | 0.6 | $27M | 500k | 54.68 | |
Turning Point Therapeutics I | 0.6 | $27M | 350k | 78.02 | |
Iteos Therapeutics (ITOS) | 0.5 | $26M | 994k | 25.65 | |
Forma Therapeutics Hldgs SHS | 0.5 | $25M | 1.0M | 24.89 | |
Trillium Therapeutics Com New | 0.5 | $24M | 2.5M | 9.70 | |
Avis Budget (CAR) | 0.5 | $23M | 300k | 77.89 | |
Atara Biotherapeutics (ATRA) | 0.5 | $23M | 1.5M | 15.55 | |
Sqz Biotech (SQZB) | 0.5 | $23M | 1.6M | 14.45 | |
Achilles Therapeutics Sponsored Ads (ACHL) | 0.4 | $22M | 2.3M | 9.79 | |
Taysha Gene Therapies Com Shs (TSHA) | 0.4 | $22M | 1.0M | 21.20 | |
Praxis Precision Medicines I | 0.4 | $22M | 1.2M | 18.28 | |
Ikena Oncology (IKNA) | 0.4 | $22M | 1.5M | 14.04 | |
Graphite Bio | 0.4 | $22M | 700k | 30.73 | |
Albireo Pharma | 0.4 | $21M | 600k | 35.18 | |
Novagold Res Com New (NG) | 0.4 | $21M | 2.6M | 8.01 | |
Black Diamond Therapeutics (BDTX) | 0.4 | $20M | 1.6M | 12.19 | |
Neximmune | 0.4 | $20M | 1.2M | 16.32 | |
Gossamer Bio (GOSS) | 0.4 | $19M | 2.4M | 8.12 | |
Foghorn Therapeutics (FHTX) | 0.4 | $18M | 1.7M | 10.67 | |
Marinus Pharmaceuticals Com New (MRNS) | 0.4 | $18M | 1.0M | 17.94 | |
Aptinyx | 0.4 | $17M | 6.1M | 2.83 | |
Repare Therapeutics Ord (RPTX) | 0.3 | $17M | 550k | 31.18 | |
Bridgebio Pharma (BBIO) | 0.3 | $17M | 275k | 60.96 | |
Selecta Biosciences (RNAC) | 0.3 | $17M | 4.0M | 4.18 | |
Ambrx Biopharma Sponsored Ads | 0.3 | $17M | 850k | 19.60 | |
Mersana Therapeutics (MRSN) | 0.3 | $16M | 1.2M | 13.58 | |
Zymeworks | 0.3 | $16M | 450k | 34.69 | |
Iqiyi Sponsored Ads (IQ) | 0.3 | $16M | 1.0M | 15.58 | |
Dlocal Class A Com (DLO) | 0.3 | $16M | 295k | 52.53 | |
Bellus Health Com New | 0.3 | $15M | 4.8M | 3.11 | |
Relay Therapeutics (RLAY) | 0.3 | $15M | 400k | 36.59 | |
Lifestance Health Group (LFST) | 0.3 | $14M | 500k | 27.86 | |
Harpoon Therapeutics | 0.3 | $14M | 1.0M | 13.87 | |
Nanobiotix Sa Sponsored Ads (NBTX) | 0.3 | $14M | 1.0M | 13.78 | |
Translate Bio | 0.3 | $14M | 500k | 27.54 | |
Evelo Biosciences | 0.3 | $14M | 1.0M | 13.74 | |
Adagene Ads (ADAG) | 0.3 | $14M | 1.0M | 13.56 | |
Y Mabs Therapeutics (YMAB) | 0.3 | $14M | 400k | 33.80 | |
Aurinia Pharmaceuticals (AUPH) | 0.3 | $13M | 1.0M | 12.96 | |
Kura Oncology (KURA) | 0.3 | $13M | 600k | 20.85 | |
Tcr2 Therapeutics Inc cs | 0.2 | $12M | 750k | 16.41 | |
Agilon Health (AGL) | 0.2 | $12M | 300k | 40.57 | |
Kymera Therapeutics (KYMR) | 0.2 | $12M | 250k | 48.50 | |
Lyell Immunopharma (LYEL) | 0.2 | $11M | 700k | 16.24 | |
Dyne Therapeutics (DYN) | 0.2 | $11M | 525k | 21.04 | |
Cyclerion Therapeutics | 0.2 | $11M | 2.8M | 3.90 | |
Adverum Biotechnologies | 0.2 | $11M | 3.0M | 3.50 | |
Curis Com New | 0.2 | $11M | 1.3M | 8.07 | |
Vor Biopharma (VOR) | 0.2 | $10M | 550k | 18.65 | |
Cytokinetics Com New (CYTK) | 0.2 | $9.9M | 500k | 19.79 | |
Ovid Therapeutics (OVID) | 0.2 | $9.8M | 2.5M | 3.91 | |
Syros Pharmaceuticals | 0.2 | $9.3M | 1.7M | 5.45 | |
Blueprint Medicines (BPMC) | 0.2 | $8.8M | 100k | 87.96 | |
111 Ads (YI) | 0.2 | $8.8M | 966k | 9.08 | |
Instil Bio | 0.2 | $8.7M | 450k | 19.32 | |
Immunic (IMUX) | 0.2 | $8.6M | 700k | 12.26 | |
Stoke Therapeutics (STOK) | 0.2 | $8.4M | 250k | 33.66 | |
Applied Therapeutics (APLT) | 0.2 | $8.3M | 400k | 20.78 | |
Solid Biosciences | 0.2 | $8.2M | 2.3M | 3.66 | |
Design Therapeutics (DSGN) | 0.2 | $8.0M | 400k | 19.89 | |
Ac Immune Sa SHS (ACIU) | 0.2 | $7.9M | 1.0M | 7.93 | |
Orchard Therapeutics Ads | 0.2 | $7.9M | 1.8M | 4.39 | |
Sana Biotechnology (SANA) | 0.2 | $7.9M | 400k | 19.66 | |
Aravive | 0.2 | $7.8M | 1.3M | 5.98 | |
Immunocore Hldgs Ads (IMCR) | 0.2 | $7.8M | 200k | 39.05 | |
Omega Alpha Spac Cl A | 0.2 | $7.5M | 750k | 9.95 | |
Deciphera Pharmaceuticals (DCPH) | 0.1 | $7.3M | 200k | 36.61 | |
Recursion Pharmaceuticals In Cl A (RXRX) | 0.1 | $7.3M | 200k | 36.50 | |
Olema Pharmaceuticals (OLMA) | 0.1 | $7.3M | 261k | 27.98 | |
Aeglea Biotherapeutics | 0.1 | $7.3M | 1.0M | 6.96 | |
Oric Pharmaceuticals (ORIC) | 0.1 | $7.1M | 400k | 17.69 | |
Spero Therapeutics (SPRO) | 0.1 | $7.0M | 500k | 13.96 | |
Contrafect Corp Com New | 0.1 | $6.6M | 1.5M | 4.40 | |
Fusion Pharmaceuticals (FUSN) | 0.1 | $6.1M | 750k | 8.08 | |
Hookipa Pharma Inc equity (HOOK) | 0.1 | $5.5M | 600k | 9.16 | |
Alpine Immune Sciences (ALPN) | 0.1 | $5.3M | 593k | 9.00 | |
Bright Health Group | 0.1 | $5.2M | 306k | 17.16 | |
Cardiff Oncology (CRDF) | 0.1 | $5.0M | 750k | 6.65 | |
Dynamics Special Purpose Cor Class A Com | 0.1 | $5.0M | 500k | 9.94 | |
Leap Therapeutics | 0.1 | $4.9M | 3.0M | 1.64 | |
Aldeyra Therapeutics (ALDX) | 0.1 | $4.9M | 432k | 11.33 | |
Seres Therapeutics (MCRB) | 0.1 | $4.8M | 200k | 23.85 | |
Mereo Biopharma Group Ads (MREO) | 0.1 | $4.8M | 1.5M | 3.17 | |
Immutep Sponsored Ads (IMMP) | 0.1 | $3.9M | 1.0M | 3.87 | |
Kaleido Biosciences Ord (KLDO) | 0.1 | $3.7M | 501k | 7.44 | |
Codiak Biosciences | 0.1 | $3.7M | 200k | 18.53 | |
Avidity Biosciences Ord (RNA) | 0.1 | $3.5M | 143k | 24.71 | |
Metacrine Ord | 0.1 | $3.5M | 925k | 3.80 | |
Viacomcbs CL B (PARA) | 0.1 | $3.4M | 75k | 45.20 | |
Sigilon Therapeutics | 0.1 | $3.0M | 276k | 10.73 | |
Kinnate Biopharma (KNTE) | 0.1 | $2.9M | 125k | 23.28 | |
Axcella Health Inc equity | 0.1 | $2.9M | 713k | 4.01 | |
Mei Pharma Com New | 0.1 | $2.9M | 1.0M | 2.85 | |
Cullinan Oncology (CGEM) | 0.1 | $2.6M | 100k | 25.75 | |
Chinook Therapeutics | 0.1 | $2.5M | 181k | 14.12 | |
Yumanity Therapeutics | 0.1 | $2.5M | 217k | 11.65 | |
Lava Therapeutics Nv SHS (LVTX) | 0.0 | $2.2M | 200k | 10.88 | |
Molecular Partners Ads (MOLN) | 0.0 | $2.0M | 100k | 20.49 | |
Chiasma | 0.0 | $1.8M | 380k | 4.73 | |
Ironwood Pharmaceuticals Com Cl A (IRWD) | 0.0 | $1.4M | 111k | 12.87 | |
Rigel Pharmaceuticals Com New (RIGL) | 0.0 | $1.4M | 321k | 4.34 | |
Cerevel Therapeutics Hldng I *w Exp 06/09/202 (CEREW) | 0.0 | $1.1M | 80k | 14.38 | |
Surface Oncology | 0.0 | $746k | 100k | 7.46 | |
Lufax Holding Ads Rep Shs Cl A | 0.0 | $565k | 50k | 11.30 | |
Cidara Therapeutics Inc Common Stock Usd 0.0001 (CDTX) | 0.0 | $454k | 225k | 2.02 |